No Data
No Data
WHO Extends Mpox Emergency; Canada Reports First Clade I Case
Bavarian Nordic: Obtained an order for 0.34 billion dollars for monkeypox and smallpox vaccines in 2025.
Gelonghui November 17th | Danish biotechnology company Bavarian Nordic stated that the total orders for monkeypox and smallpox vaccines in 2025 are approximately 0.34 billion US dollars.
Vaccine Stocks Drop on Concerns About RFK Jr. Heading HHS
Bavarian Nordic Reports Results for First Nine Months; Reaffirms Upgraded Guidance for FY24
BAVARIAN NORDIC SPON ADR EA REPR 0.3333 ORD(BVNRY.US) will release its financial report on November 15th.
Bavarian Nordic SPON ADR EA REPR 0.3333 ORD (BVNRY.US) will release its financial report on November 15th. How was the previous performance? Bavarian Nordic SPON ADR EA REPR 0.3333 ORD (BVNRY.US) had revenue of 1.427497 billion DKK, net income of 0.261128 billion DKK, and earnings per share of 1.1 DKK in 2024/Q2. Revenue in 2023/Q3
First Mpox Case Linked to African Outbreak Reported in U.K.
Unlock the Full List